Peer-influenced content. Sources you trust. No registration required. This is HCN.

Articles related to MYASTHENIA GRAVIS

UCSF MedConnection

Telehealth Referral Leads to Diagnosis and Effective Treatment of Rare Neuropathy: Case Study

Endocrinology, Diabetes, Metabolism January 29th 2024

Practical Neurology

FDA Approves Zilbrysq as First Once-Daily Subcutaneous C5 Inhibitor for Generalized Myasthenia Gravis

Neurology October 24th 2023

Cleveland Clinic Journal of Medicine

What are the Treatment Options for Myasthenia Gravis if First-line Agents Fail?

Neurology February 28th 2023


Complement and the Prothrombotic State

Hematology April 5th 2022

The Healthcare Communications Network is owned and operated by IQVIA Inc.

Click below to leave this site and continue to IQVIA’s Privacy Choices form